Transcripts Blueprint Medicines Corporation

Equities

BPMC

US09627Y1091

Market Closed - Nasdaq Other stock markets 01:30:00 09/05/2024 am IST			5-day change	1st Jan Change
108.8 ^USD	+0.21%		+14.67%	+17.93%

06/05	Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing	MT
06/05	Goldman Sachs Adjusts Price Target on Blueprint Medicines to $168 From $121, Maintains Buy Rating	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Blueprint Medicines Corporation, Q1 2024 Earnings Call, May 02, 2024	02/05
Transcript : Blueprint Medicines Corporation - Special Call	25/04
Transcript : Blueprint Medicines Corporation, Q4 2023 Earnings Call, Feb 15, 2024	15/02
Transcript : Blueprint Medicines Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 10:30 AM	09/01
Transcript : Blueprint Medicines Corporation, Q3 2023 Earnings Call, Oct 26, 2023	26/23/26
Transcript : Blueprint Medicines Corporation Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 11:20 AM	11/23/11
Transcript : Blueprint Medicines Corporation, Q2 2023 Earnings Call, Aug 02, 2023	02/23/02
Transcript : Blueprint Medicines Corporation Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 09:20 AM	14/23/14
Transcript : Blueprint Medicines Corporation - Special Call	23/23/23
Transcript : Blueprint Medicines Corporation, Q1 2023 Earnings Call, May 04, 2023	04/23/04
Transcript : Blueprint Medicines Corporation Presents at Barclays Global Healthcare Conference, Mar-15-2023 02:35 PM	16/23/16
Transcript : Blueprint Medicines Corporation - Special Call	27/23/27
Transcript : Blueprint Medicines Corporation, Q4 2022 Earnings Call, Feb 16, 2023	16/23/16
Transcript : Blueprint Medicines Corporation Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 04:30 PM	11/23/11
Transcript : Blueprint Medicines Corporation - Analyst/Investor Day	01/22/01
Blueprint Medicines Corporation Provides Revenue Guidance for 2022	01/22/01	CI
Transcript : Blueprint Medicines Corporation - Special Call	17/22/17
Transcript : Blueprint Medicines Corporation, Q2 2022 Earnings Call, Aug 02, 2022	02/22/02
Blueprint Medicines Corporation Provides Revenue Guidance for 2022	02/22/02	CI
Transcript : Blueprint Medicines Corporation - Special Call	30/22/30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts Blueprint Medicines Corporation

Equities

BPMC

US09627Y1091

Transcripts

Filters